Elevated Levels of Plasma C-Reactive Protein Are Associated With Decreased Graft Survival in Cardiac Transplant Recipients
Explore this paper's citation graph
Summary
Elevated plasma levels of CRP are associated with subsequent allograft failure in cardiac transplant recipients, suggesting that systemic inflammation may be involved in the origin of transplant coronary artery disease.
- Type
- article
- Published
- 2000-10-24
- Cited by
- 94
- References
- 60
- Access
- Open access
- OpenAlex
- https://openalex.org/W11044427
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:7271616
Keywords
Computer science
References
- Cardiac release of cytokines and inflammatory responses in acute myocardial infarction.
- HEMOSTATIC CHANGES IN HEART TRANSPLANT RECIPIENTS AND THEIR RELATIONSHIP TO ACCELERATED CORONARY SCLEROSIS
- Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.
- Prospective Studies of C-Reactive Protein as a Risk Factor for Cardiovascular Disease
- C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor.
- Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.
- CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes.
- Increased immunoreactive endothelin-1 in human transplant coronary artery disease.
- Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.
- C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.
- Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection.
- The role of inflammation in the development of allograft coronary disease.
- Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.
- Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
- Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.
- Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.
- Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.
- Predictive Value of Tissue Plasminogen Activator Mass Concentration on Long‐term Mortalit in Patients With Coronary Artery Disease A 7‐Year Follow‐up
- Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.
- Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease.
Cited by
- Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post‐heart transplant in paediatric patients
- C-Reactive protein and cardiac allograft vasculopathy. is inflammation the critical link?
- Cardiac allograft vasculopathy
- Biomarker zur Diagnose der zellulären Abstoßung nach Herztransplantation
- Feasibility of using C-reactive protein for point-of-care testing
- C-reactive protein as a novel biomarker
- Macrophage activation is associated with poorer long‐term outcomes in renal transplant patients
- Cardiac allograft vasculopathy: current knowledge and future direction
- Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia.
- The promise of protein-based and gene-based clinical markers in heart transplantation: from bench to bedside
- Surrogate Markers for Late Cardiac Allograft Survival
- “Tolerance” assays: the physician's guide to safe weaning of immunosuppression?
- Plasma C-reactive protein levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
- Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, c-reactive protein, and mean platelet volume.
- Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users.
- Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.
- Calcitriol Deficiency and 1-Year Mortality in Cardiac Transplant Recipients
- C-reactive protein: a 'golden marker' for inflammation and coronary artery disease.
- Probrain Natriuretic Peptide and C-Reactive Protein as Markers of Acute Rejection, Allograft Vasculopathy, and Mortality in Heart Transplantation
- Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients
Related papers
No related papers recorded.